Cutaneous adverse events related to simultaneous nevirapine treatment and pneumococcal vaccination in HIV-infected patients
Estrada, V.; de Villar, N.; Serrano-Ríos, M.
Medicina Clinica 116(12): 479
2001
ISSN/ISBN: 0025-7753 PMID: 11333714 Document Number: 534530
Document emailed within 1 workday
Related Documents
Manosuthi, W.; Kiertiburanakul, S.; Chaovavanich, A.; Sungkanuparph, S. 2007: Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients Journal of the Medical Association of Thailand 90(2): 244-250Okada, K. 2011: Adverse events following vaccination Nihon Rinsho. Japanese Journal of Clinical Medicine 69(9): 1639-1643
Emmungil, H.; Durusoy, R.; Kalfa, M.; Yargucu Zihni, F.; Özmen, M.; Keser, Gökhan.; Gücenmez, S.; Yilmaz, Z.; Aksu, K. 2015: Plasma thiopurine S-methyltransferase levels and azathioprine-related adverse events in patients with Behçet's disease Clinical and Experimental Rheumatology 33(6 Suppl. 94): S40-S45
Kondo, W.; Astori, A.de.Assis.Fischer.de.; Gomes, S.El-Kouba.; Fernandes, R.de.Brito.; Sasaki, M.das.Graças.; Sbalqueiro, R.Luiz. 2008: Evaluation of the adverse effects of nevirapine in HIV-infected pregnant women in a South Brazilian University Hospital Revista Brasileira de Ginecologia e Obstetricia: Revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 30(1): 19-24
Kondo, W.; Astori, A.de.Assis.Fischer.de.; Gomes, S.El-Kouba.; Fernandes, R.de.Brito.; Sasaki, M.das.Graças.; Sbalqueiro, R.Luiz. 2008: Evaluation of the adverse effects of nevirapine in HIV-infected pregnant women in a South Brazilian University Hospital Revista Brasileira de Ginecologia e Obstetricia: Revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 30(1): 19-24
Li, S.L.; Gao, X.P.; Chen, Q.Q.; Fu, X.H.; Zhao, Y.; Duan, J.M.; Tang, Y.Q.; Sun, J.; Li, J.L.; Zhou, Q.M. 2020: Retrospectively analysis of characteristics and risk factors of immune treatment-related hepatic adverse events in malignant tumor Zhonghua Zhong Liu Za Zhi 42(1): 50-54
Kemper, A.R.; Davis, M.M.; Freed, G.L. 2002: Expected adverse events in a mass smallpox vaccination campaign Effective Clinical Practice: Ecp 5(2): 84-90
Pakhomov, D.V.; Kostinov, M.P.; Poddubikov, A.V.; Vaneeva, N.P.; Snegova, N.F.; Nikitina, T.N.; Zinkina, T.N.; Suloeva, S.V. 2009: Immunological effect of vaccination against pneumococcal infection in HIV-infected children Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 48-52
Fortuna, L.; Sirivichayakul, C.; Watanaveeradej, V.; Soonthornworasiri, N.; Sitcharungsi, R. 2015: Adverse Events Post-Dtap and Dtwp Vaccination in Thai Children Southeast Asian Journal of Tropical Medicine and Public Health 46(4): 764-774
Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Labadie, J.; van Grootheest, A.C. 2007: Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006 Nederlands tijdschrift voor geneeskunde 151(49): 2738-2742
Bezruchka, S. 2001: Adverse events in British hospitals. Expanded definition of adverse events is needed Bmj 322(7299): 1427
Yamashita, H.; Tsukayama, H.; Tanno, Y.; Nishijo, K. 1998: Adverse events related to acupuncture JAMA 280(18): 1563-1564
Manosuthi, W.; Tantanathip, P.; Chimsuntorn, S.; Eampokarap, B.; Thongyen, S.; Nilkamhang, S.; Sungkanuparph, S. 2010: Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(11): E1013-E1017
Barsky, E. 2014: Serious adverse events related to primary care Soins. Gerontologie 2014(110): 6
Anekthananon, T.; Ratanasuwan, W.; Techasathit, W.; Sonjai, A.; Suwanagool, S. 2004: Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study Journal of the Medical Association of Thailand 87(7): 760-767
Moiseev, S.V.; Novikov, P.I.; Semenkova, E.N.; Strizhakov, L.A.; Gulyaev, S.V.; Yanushkevich, T.N.; Nikiforova, N.V.; Meshkov, A.D.; Panasyuk, V.V.; Sokorin, Y.D.; Taranova, M.V.; Parfenova, S.A.; Dubrovskaya, L.V.; Zhabina, E.S.; Kuznetsova, E.I.; Lopatina, I.A.; Bulanov, N.M.; Mukhin, N.A. 2013: Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases Terapevticheskii Arkhiv 85(5): 37-43
Shore, N.D.; Sieber, P.; Schimke, L.; Perzin, A.; Olsen, S. 2013: Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer Urologic Nursing 33(5): 236-44 248
Galindo, B.M.; Concepción, D.; Galindo, M.A.; Pérez, A.; Saiz, Jús. 2012: Vaccine-related adverse events in Cuban children, 1999-2008 MEDICC review 14(1): 38-43
Popoola, T.D.; Awodele, O.; Oshikoya, K.A. 2016: A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria African Journal of Medicine and Medical Sciences 45(2): 179-187